CHMP recommends against EU approval of MS drug Nerventra®
Posted: Tue Jan 28, 2014 10:10 pm
CHMP recommends against EU approval of MS drug Nerventra® (Laquinimod)
The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has recommended against approval of a new drug for multiple sclerosis (MS).
During their monthly meeting on January 23, the CHMP panel adopted a negative opinion on granting marketing authorization for laquinimod ( Nerventra, Teva Pharma) in patients with relapsing-remitting MS..... Read More - http://www.ms-uk.org/laquinimod
The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has recommended against approval of a new drug for multiple sclerosis (MS).
During their monthly meeting on January 23, the CHMP panel adopted a negative opinion on granting marketing authorization for laquinimod ( Nerventra, Teva Pharma) in patients with relapsing-remitting MS..... Read More - http://www.ms-uk.org/laquinimod